the National Key Research and Development Program(2022YFC2603500,2022YFC2603505);Beijing Municipal Health Commission high-level public health technical personnel construction project,discipline leader-03-26,Beijing Hospitals Authority Clinical medicine Development of special funding support(XMLX 202127);the capital health research and development of special public health project(2022-1-2172);The Digestive Medical Coordinated Development Center of Beijing Hospitals Authority(XXZ0302).
To explore the impact of ursodeoxycholic acid(UDCA)on severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection and clinical outcomes in patients with autoimmune liver disease(AILD).Patients diagnosed with ...
supported by the grant from the Research Foundation of Education Bureau of Hunan Province,China(No.19B490).
Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)has resulted in the current outbreak of coronavirus disease 2019(COVID-19)in humans,causing worldwide health issues[1].The periodic and unexpected consequence...